Published in PLoS One on May 01, 2015
Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovasc Res (2016) 0.91
Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? Eur Heart J (2016) 0.87
Novel epigenetic-based therapies useful in cardiovascular medicine. World J Cardiol (2016) 0.77
Should we expect novel biomarkers of myocardial infarction? Ann Transl Med (2016) 0.75
Knockdown of MicroRNA-122 Protects H9c2 Cardiomyocytes from Hypoxia-Induced Apoptosis and Promotes Autophagy. Med Sci Monit (2017) 0.75
Elevated plasma miRNA-122, -140-3p, -720, -2861, and -3149 during early period of acute coronary syndrome are derived from peripheral blood mononuclear cells. PLoS One (2017) 0.75
The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet (2010) 3.75
miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol (2008) 2.61
Biological functions of microRNAs: a review. J Physiol Biochem (2010) 2.38
Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation (2013) 2.22
MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation (2010) 2.07
Troponin elevation in coronary vs. non-coronary disease. Eur Heart J (2010) 1.93
MicroRNAs in lipid metabolism. Curr Opin Lipidol (2011) 1.79
A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem (2011) 1.57
Acute coronary events. Circulation (2012) 1.54
Expression of microRNAs in basal cell carcinoma. Br J Dermatol (2012) 1.50
MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation (2013) 1.33
MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol (2011) 1.26
Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis (2012) 1.24
Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol (2012) 1.20
miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Carcinogenesis (2013) 1.18
MicroRNAs in platelet production and activation. Blood (2011) 1.17
Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) (2010) 1.17
Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis. Med Oncol (2013) 1.01
The clinical manifestation of myocardial infarction in elderly patients. Clin Cardiol (2009) 0.97
Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J (1998) 0.93
Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra? Trends Cardiovasc Med (2010) 0.93
MicroRNA: A matter of life or death. World J Biol Chem (2010) 0.91
Circulating miRNAs: novel biomarkers of acute coronary syndrome? Biomark Med (2013) 0.91
microRNA expression profiling in multidrug resistance of the 5‑Fu‑induced SGC‑7901 human gastric cancer cell line. Mol Med Rep (2013) 0.90
MicroRNAs in the atherosclerotic plaque. Clin Chem (2013) 0.90
MicroRNAs in platelet biogenesis and function. Thromb Haemost (2012) 0.84